Kate Shaffar Group

Clinical diagnostics heavily rely on accurate blood typing, making the Blood Grouping Reagents Market critical for modern healthcare. Blood grouping reagents ensure safe transfusions, reduce complications, and assist in organ transplant compatibility testing.

Hospitals, blood banks, and laboratories are increasingly adopting automated solutions and advanced reagents to meet the growing demand for safe and efficient diagnostic workflows. Government programs supporting blood safety are also contributing to market growth.

Market Outlook: Valued at USD 1.2 billion in 2024, the market is expected to reach USD 2.5 billion by 2034, expanding at a 7.1% CAGR.